id	domain	url
gs-2559	doi.org	https://doi.org/10.52340/gs.2024.06.01.09
gs-2559	www.ema.europa.eu	https://www.ema.europa.eu/en/glossary/biological-medicine
gs-2559	www.fda.gov	https://www.fda.gov/files/drugs/published/biological-product-definitions.pdf
gs-2559	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/presentation/presentation-manufacturing-processbiologics-kowid-ho-afssaps_en.pdf
gs-2559	www.ema.europa.eu	https://www.ema.europa.eu/en/human-regulatory-overview/marketing-authorisation/genericand-hybrid-medicines
gs-2559	www.fda.gov	https://www.fda.gov/drugs/buying-using-medicine-safely/generic-drugs
gs-2559	www.fda.gov	https://www.fda.gov/drugs/therapeutic-biologics-applications-bla/biosimilars
gs-2559	www.who.int	http://www.who.int/biologicals/publications/trs/areas/biological_therapeutics/trs_977_annex_
gs-2559	www.ema.europa.eu	https://www.ema.europa.eu/en/human-regulatoryoverview/biosimilar-medicines-overview
gs-2559	www.ema.europa.eu	https://www.ema.europa.eu/en/similar-biological-medicinal-products-scientific-guideline
gs-2559	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/leaflet/biosimilars-euinformation-guide-healthcare-professionals_en.pdf
gs-2559	www.ema.europa.eu	https://www.ema.europa.eu/en/ich-q5e-biotechnological-biological-products-subjectchanges-their-manufacturing-process-comparability-biotechnological-biological-productsscientific-guideline
gs-2559	www.ema.europa.eu	https://www.ema.europa.eu/en/ich-q6b-specifications-testprocedures-and-acceptance-criteria-biotechnological-biological-products-scientific-guideline
gs-2559	www.ema.europa.eu	https://www.ema.europa.eu/en/immunogenicity-assessment-biotechnology-derivedtherapeutic-proteins-scientific-guideline
gs-2559	www.who.int	https://www.who.int/teams/health-product-policy-andstandards/standards-and-specifications/monoclonal-antibodies